Comparison Chart DiaMedica Therapeutics Inc.
Stocks
DMAC
CA25253X2077
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 7.780 USD | +7.16% |
|
+19.14% | -2.26% |
| 08-11 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-10 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Bio Therapeutic Drugs | +7.16% | +19.14% | -2.26% | +11.46% | +101.03% | 392M |
-
|
-
|
-
|
- Stock Market
- Stocks
- DMAC Stock
- Charts DiaMedica Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
